Thomas P. Johnston

Regression of poloxamer 407-induced atherosclerotic lesions in C57BL/6 mice using atorvastatin.

T. Johnston, E. Emeson, W. K. Palmer, 2000, Atherosclerosis.

Poloxamer 407-induced atherogenesis in the C57BL/6 mouse.

T. Johnston, T P Johnston, E. Emeson, 1998, Atherosclerosis.

Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat.

T. Johnston, T P Johnston, W. K. Palmer, 1993, Biochemical pharmacology.

Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis.

S. Shefer, T. Johnston, L. Nguyen, 2001, International journal of pharmaceutics.

The poloxamer 407-induced hyperlipidemic atherogenic animal model.

T. Johnston, E. Emeson, W. K. Palmer, 1997, Medicine and science in sports and exercise.

Effect of poloxamer 407 on the activity of microsomal 3-hydroxy-3-methylglutaryl CoA reductase in rats.

T. Johnston, W. K. Palmer, Thomas P. Johnston, 1997, Journal of cardiovascular pharmacology.